Stock Analysis

Lectra And Two Euronext Paris Growth Stocks With High Insider Ownership

ENXTPA:MEDCL
Source: Shutterstock

Amidst a backdrop of fluctuating European indices, with France's CAC 40 Index recently witnessing a notable decline, investors are keenly observing market movements and potential opportunities. In such a landscape, growth companies with high insider ownership in France may offer unique appeal, suggesting strong confidence from those closest to the company's operations and future prospects.

Top 10 Growth Companies With High Insider Ownership In France

NameInsider OwnershipEarnings Growth
VusionGroup (ENXTPA:VU)13.5%25.2%
Groupe OKwind Société anonyme (ENXTPA:ALOKW)24.8%30.8%
Adocia (ENXTPA:ADOC)11.9%63%
Icape Holding (ENXTPA:ALICA)30.2%26.2%
La Française de l'Energie (ENXTPA:FDE)20.1%31.9%
Arcure (ENXTPA:ALCUR)21.4%27.5%
S.M.A.I.O (ENXTPA:ALSMA)17.3%35.2%
Munic (ENXTPA:ALMUN)29.4%149.2%
OSE Immunotherapeutics (ENXTPA:OSE)25.6%5.9%
MedinCell (ENXTPA:MEDCL)16.4%69.6%

Click here to see the full list of 21 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Lectra (ENXTPA:LSS)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, and furniture sectors across Northern Europe, Southern Europe, the Americas, and Asia Pacific, with a market capitalization of approximately €1.09 billion.

Operations: Lectra's revenue is generated primarily from the Americas and Asia-Pacific regions, with contributions of €170.33 million and €110.28 million respectively.

Insider Ownership: 19.6%

Lectra, a French company with high insider ownership, shows promising financial dynamics despite a slight dip in net income as reported in its recent earnings for Q1 2024. With sales increasing to €129.56 million from €123.65 million year-over-year, the company is poised for growth. Analysts project Lectra's earnings will grow by 28.6% annually over the next three years, outpacing the French market's average. Additionally, its stock is considered undervalued, trading at 35.3% below estimated fair value, suggesting potential upside according to consensus forecasts.

ENXTPA:LSS Earnings and Revenue Growth as at Jul 2024
ENXTPA:LSS Earnings and Revenue Growth as at Jul 2024

MedinCell (ENXTPA:MEDCL)

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a French pharmaceutical company that specializes in developing long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €463.23 million.

Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling €11.95 million.

Insider Ownership: 16.4%

MedinCell, a French growth company with significant insider ownership, is set to outpace the market with an expected annual revenue increase of 43.8%. Despite a recent net loss of €25.04 million, down from €32.01 million the previous year, MedinCell is forecasted to turn profitable within three years. The firm's commitment to innovation was evident at the Jefferies Global Healthcare Conference and in its promising, though mixed-results Phase 3 trial of F14 for post-surgical pain management.

ENXTPA:MEDCL Earnings and Revenue Growth as at Jul 2024
ENXTPA:MEDCL Earnings and Revenue Growth as at Jul 2024

OVH Groupe (ENXTPA:OVH)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market capitalization of approximately €1.10 billion.

Operations: OVH Groupe's revenue is segmented into Public Cloud (€169.01 million), Private Cloud (€589.61 million), and Web Cloud (€185.43 million).

Insider Ownership: 10.5%

OVH Groupe, a French growth company with substantial insider ownership, is trading 23.9% below its estimated fair value, indicating potential undervaluation. Despite its highly volatile share price recently, OVH's revenue is expected to grow by 10% annually, outpacing the French market's 5.6%. The company anticipates becoming profitable within three years with earnings forecasted to surge by 101.12% per year. However, its projected Return on Equity in three years is low at 1.7%. Recent innovations include launching advanced servers that enhance performance and price efficiency.

ENXTPA:OVH Ownership Breakdown as at Jul 2024
ENXTPA:OVH Ownership Breakdown as at Jul 2024

Turning Ideas Into Actions

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Valuation is complex, but we're helping make it simple.

Find out whether MedinCell is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com